Japan’s largest drugmaker Takeda (announced new Phase III data for zasocitinib, its investigational, next-generation, highly ...

UK biotech company Mission Therapeutics has agreed to hand its acute kidney injury candidate MTX652 to Australian renal ...

Sidera Bio is headquartered in Copenhagen, Denmark, with a U.S. presence in Cambridge, Massachusetts. The company operates across the European and U.S. biotech ecosystems and is focused on developing ...

A clinical-stage biotech company headquartered in San Diego, focused on advancing RNA-based medicines for serious and underserved diseases. Founded in 2022 and backed initially by Apricot Capital, the ...

A clinical-stage immunology company based in the United States, operating within the Boston biotechnology ecosystem. Poplar Therapeutics was previously known as Phylaxis Bioscience and was ...

Latin American countries need to treat health spending as an investment rather than a cost if they are to expand coverage, ...

US lawmakers have introduced bipartisan legislation that would reduce routine reliance on comparative clinical efficacy studies in biosimilar approvals, a move welcomed by the Association for ...

US healthcare major Johnson & Johnson (NYSE: JNJ) reported second-quarter 2026 sales of $25.31 billion, up 6.6% on the year, ...

An early-stage biotech company focused on discovering and developing human therapeutics. The company is funded by Osage University Partners, Hatteras Venture Partners, Delin Ventures and Alexandria ...

Biogen (Nasdaq: BIIB) saw its shares fall 8% on Tuesday after a fuller look at mid-stage results for its experimental ...

Swiss generics and biosimilars company Sandoz (SIX: SDZ) has announced a set of senior leadership changes designed to sharpen its operations and dealmaking ahead of what it calls a "golden decade" of ...

India's Zydus Lifesciences has entered into a strategic deal to acquire select assets of Sterling Biotech, strengthening its ...